Literature DB >> 2805417

Enhancement in number and function of antigen-presenting cells in the lymphatic tissue of rats after in vivo administration of diphenylhydantoin (DPH).

S Petrasch1, H H Wacker, P Zou, D Bechtold, G Brittinger.   

Abstract

We present a monoclonal IgG1 antibody, KiMy1R, which is specific for macrophages and their derivatives in the lymphatic tissue of the rat, and evaluate the distribution of subsets of mononuclear cells in popliteal and para-aortal lymph nodes of Wistar rats after injection of 50 mg DPH into the hindpads. Compared with resting lymphatic tissue and lymph nodes of animals treated with phenobarbital, DPH induced a significant increase (P less than 0.01) of the proportion of phagocytic cells. Furthermore, the soluble antigen alkaline phosphatase was traced after inoculation into the footpads of rats: in locoregional lymph nodes the percentage (mean 12.8/10(3] and the total number (mean 476 x 10(3) cells/lymph node) of cells with membrane-bound or intracytoplasmic alkaline phosphatase, as detected by a monoclonal anti-alkaline phosphatase antibody, were significantly higher (P less than 0.001) in animals pretreated with DPH than in rats pretreated with phenobarbital (mean 2.1/10(3); 31.2 x 10(3) cells/lymph node) and in untreated animals (mean 1.9/10(3); 4.1 x 10(3) cells/lymph node). If verified in humans, the effect of DPH in enhancing the number and function of macrophages and other antigen-presenting cells may exert favourable effects in patients with impairment of the mononuclear phagocytic system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805417      PMCID: PMC1534602     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas.

Authors:  S L SALTZSTEIN; L V ACKERMAN
Journal:  Cancer       Date:  1959 Jan-Feb       Impact factor: 6.860

2.  [Diphenylhydantoin in the prevention and therapy of AIDS?].

Authors:  H A Lehr; J P Zimmer
Journal:  Dtsch Med Wochenschr       Date:  1986-06-20       Impact factor: 0.628

3.  Ineffectiveness of phenytoin treatment on IgA-containing circulating immune complexes in IgA nephropathy.

Authors:  R Coppo; B Basolo; M R Bulzomi; G Piccoli
Journal:  Nephron       Date:  1984       Impact factor: 2.847

4.  Combined immunohistochemical staining for surface IgD and T-lymphocyte subsets with monoclonal antibodies in human tonsils.

Authors:  A C Feller; M R Parwaresch; H H Wacker; H J Radzun; K Lennert
Journal:  Histochem J       Date:  1983-06

5.  Studies on the mechanism of drug sensitization: T-cell-dependent popliteal lymph node reaction to diphenylhydantoin.

Authors:  H Gleichmann
Journal:  Clin Immunol Immunopathol       Date:  1981-02

6.  T cell-dependent B cell lymphoproliferation and activation induced by the drug diphenylhydantoin.

Authors:  H Gleichmann; S Pals; T Radaszkiewicz; M Wasser
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

7.  Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.

Authors:  T C Sorrell; I J Forbes
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

8.  Phenytoin potentiates accessory cell dependent DNA-synthesis in human lymphocytes in vitro.

Authors:  G Dahllöf; P Otteskog; T Modéer
Journal:  Scand J Dent Res       Date:  1986-06

9.  Phenytoin-induced connective tissue growth in the rat.

Authors:  R E Dill; R G Jones; W L Davis
Journal:  Anat Rec       Date:  1986-06

10.  The effect of phenytoin in vitro on normal human mononuclear cells and on human lymphoblastoid B cell lines of different Ig isotype specificities.

Authors:  A G Wangel; H Arvilommi; I Jokinen
Journal:  Immunobiology       Date:  1985-09       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.